
<DOC>
<DOCNO>WT02-B19-10</DOCNO>
<DOCOLDNO>IA092-000988-B015-25</DOCOLDNO>
<DOCHDR>
http://www.cytrx.com:80/vetlife.htm 206.216.36.35 19970110094001 text/html 4102
HTTP/1.0 200 OK
Date: Friday, 10-Jan-97 09:42:46 GMT
Server: WebSite/1.1
Allow-ranges: bytes
Accept-ranges: bytes
Content-type: text/html
Last-modified: Friday, 03-Jan-97 17:19:10 GMT
Content-length: 3887
</DOCHDR>
<HTML>

<HEAD>

<TITLE> Vetlife Background Information</TITLE>

<META NAME="GENERATOR" CONTENT="Internet Assistant for Microsoft Word 2.0z">
</HEAD>

<BODY background=/icons/wrich/bg.gif>

<table width=95%><tr>
<td align=left>	
	<img src=/icons/cytrx.48pt.gif>
	</td>

<td align=right>
	<img src=/icons/multiopp.gif>
	</td>
</tr></table>
<img src=/icons/wrich/redline.gif>

<P>
<IMG  SRC="vetlife.gif" ALIGN="right" WIDTH=75 HEIGHT=75 HSPACE=50>
<B><FONT SIZE=4>Vetlife, Inc.</FONT></B><BR>
<B><FONT SIZE=4>154 Technology Parkway</FONT></B><BR>
<B><FONT SIZE=4>Norcross, Georgia  30092</FONT></B><BR>
<B><FONT SIZE=4>(770) 453-0170<BR>
</FONT></B>
<BR>
<P>
<BR>
<TABLE BORDER=0 cellspacing=1 cellpadding=5>
   <TD VALIGN=top><B>Business<BR>Strategy: </B></TD>
   <TD>
Vetlife is an animal health company focused on bringing novel
 technologies to market to enhance cattle productivity and end
product quality without  compromising human food safety or the
environment.  Vetlife is utilizing its developmental resources
in two key areas that fit the cattle focus:  one is on novel adjuvants
to enhance cattle vaccines and the second is on anti-infective
agents to potentiate cattle antibacterials used to treat respiratory
diseases.<BR><P></TD>
<TR>
  <TD VALIGN=top><B>Vetlife, Inc: </B></TD>
   <TD>In addition to cattle products,Vetlife is
engaged in the development, licensing and marketing of technologies
to improve the value of food animal products to the poultry, swine
and dairy industries.  Products under development include a non-antibiotic
growth promoter for use in poultry and swine, adjuvants to enhance
animal vaccines and antibiotic potentiators to overcome antibiotic
resistance or reduce required doses.  <BR><P> </TD>
<TR>
   <TD VALIGN=top><B>Opportunity: </B></TD>
   <TD>As of January, 1997, the Vetlife Cattle Marketing
Group will become Ivy Laboratories' Master Distributor
in North America to market and distribute Ivy's line of
FDA approved cattle growth promotant products.<P></TD>
<TR>
   <TD VALIGN=top><B>Products: </B></TD>
   <TD>Implants used to enhance growth rate and improve
cattle feed efficiency.<P>
</TD>
<TR>
   <TD VALIGN=top><B>Implant <BR>Market:</B></TD>
   <TD>
Approximately $85 million in North American sales.
 Implants are used by   95% of “confined-fed”
beef producers and 50% of “non-confined” producers. <P></TD>
<TR>
   <TD VALIGN=top><B>Management:</B></TD>
   <TD> The Vetlife Cattle Marketing Group will be
managed by Richard Shuler, Vetlife's President and CEO,
Lynn Godbersen, Vice President and Kevin DeHaan, Ph.D., Technical
Services Manager.  Lynn was formerly Syntex's implant business
unit manager and Kevin was Syntex's beef cattle technical
services manager. <P></TD>
<TR>
   <TD VALIGN=top><B>Facilities: </B></TD>
   <TD>The main distribution center and offices will
be located near Des Moines, Iowa. <P></TD>
<TR>
   <TD VALIGN=top><B>Organization <BR>Structure: </B></TD>
   <TD>The Vetlife team is comprised of highly talented,
cattle-focused, former  Syntex managers, each
having solid knowledge, experience and provensuccess
in marketing cattle implants. <P></TD>
<TR>
   <TD VALIGN=top><B>Value Provided: </B></TD>
   <TD>Strong respected leadership and relationship
with the cattle industry and distributors; high level of knowledge
of markets, customers and competition; top quality marketing,
sales and technical service expertise; and novel cattle technology
development. <P></TD>
</TABLE>
<img src="/icons/rain_line.gif">	
<p>
<b>
[ <a href="/index.html">Home</a> 
| <a href="http://www.titermax.com">TiterMax</a> 
| <a href="/financial/overview.html">Investor Info</a> 
| <a href="/communications.html">Communications</a> 
| <a href="/adproceu.html">Proceutics</a>  
] </b>
<p>
</BODY>

</HTML>


</DOC>